Lateral flow assay reader apparatus

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of a lateral flow assay reader apparatus showing the new design.

FIG. 2 is a front elevational view thereof.

FIG. 3 is a top plan view thereof.

FIG. 4 is a right side elevational view thereof, the left side being a mirror image.

FIG. 5 is a bottom plan view thereof; and,

FIG. 6 is a rear elevational view thereof.

The cable and mobile phone shown in broken lines represent environmental structures and form no part of the claimed design; the broken lines form no part of the claimed design.

Claims

We claim the ornamental design for a lateral flow assay reader apparatus, as shown and described.

Referenced Cited
U.S. Patent Documents
8889424 November 18, 2014 Ehrenkranz et al.
8935007 January 13, 2015 Kloepfer et al.
9244066 January 26, 2016 O'Driscoll et al.
D759253 June 14, 2016 Bar-Or
D762860 August 2, 2016 He
D800320 October 17, 2017 Nishikawa
D802768 November 14, 2017 Rider
D809143 January 30, 2018 Long
9903857 February 27, 2018 Polwart et al.
10054584 August 21, 2018 Ehrenkranz et al.
D829337 September 25, 2018 Klein
D845503 April 9, 2019 Jensen
D887559 June 16, 2020 Esfandiari
D907795 January 12, 2021 Buie
D922588 June 15, 2021 Long
20070131552 June 14, 2007 Jung et al.
20130157351 June 20, 2013 Ozcan et al.
20140057362 February 27, 2014 Markovsky
20150309008 October 29, 2015 Adelman et al.
20160077091 March 17, 2016 Tyrrell et al.
20180045723 February 15, 2018 Mäkinen et al.
20190187139 June 20, 2019 Xie
20190317115 October 17, 2019 MacLean
Foreign Patent Documents
201830041760 October 2018 CN
Other references
  • Abingdon Health. FDA registration and CE marking of new lateral flow immunoassay Reader—ADxLR5®. Published Jul. 22, 2016. Retrieved from website at: https://www.abingdonhealth.com/news/fda-registration-ce-marking-new-lateral-flow-immunoassay-reader/.
Patent History
Patent number: D960385
Type: Grant
Filed: Sep 17, 2019
Date of Patent: Aug 9, 2022
Assignee: Abbott Rapid Diagnostics International Unlimited Company (Dublin)
Inventors: Axel Schubert (Jena), Thomas Ullrich (Jena), Sören Geist (Jena), Martin Stohr (Jena), Christopher Deppisch (Jena), Michael Winterot (Jena), Ilka Schlesiger (Jena)
Primary Examiner: Anhdao Doan
Application Number: 29/705,939